Systemic lupus erythematosus and other autoimmune rheumatic diseases ...

systemic lupus erythematosus, the auotantibodies that correlate with disease activity are secreted by short-lived plasma cells, indicative of B-cell hyperactivity. These disease-associated antibodies are susceptible to depletion by rituximab.12 This drug has been approved for the treatment of non-Hodgkin lymphoma and rheu matoid arthritis. ................
................